Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Modification of aminosilanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3T MRI, small animal PET, and fluorescence imaging.

Stelter L, Pinkernelle JG, Michel R, Schwartländer R, Raschzok N, Morgul MH, Koch M, Denecke T, Ruf J, Bäumler H, Jordan A, Hamm B, Sauer IM, Teichgräber U.

Mol Imaging Biol. 2010 Jan-Feb;12(1):25-34. doi: 10.1007/s11307-009-0237-9. Epub 2009 Jul 7.

PMID:
19582510
2.

Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology.

Cheon J, Lee JH.

Acc Chem Res. 2008 Dec;41(12):1630-40. doi: 10.1021/ar800045c.

PMID:
18698851
3.

PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.

Lee HY, Li Z, Chen K, Hsu AR, Xu C, Xie J, Sun S, Chen X.

J Nucl Med. 2008 Aug;49(8):1371-9. doi: 10.2967/jnumed.108.051243. Epub 2008 Jul 16.

4.

An orthotopic model of pancreatic somatostatin receptor (SSTR)-positive tumors allows bimodal imaging studies using 3T MRI and animal PET-based molecular imaging of SSTR expression.

Stelter L, Amthauer H, Rexin A, Pinkernelle J, Schulz P, Michel R, Denecke T, Stiepani H, Hamm B, Wiedenmann B, Scholz A.

Neuroendocrinology. 2008;87(4):233-42. Epub 2007 Nov 16.

PMID:
18025811
5.

Fluorescent bacterial magnetic nanoparticles as bimodal contrast agents.

Lisy MR, Hartung A, Lang C, Schüler D, Richter W, Reichenbach JR, Kaiser WA, Hilger I.

Invest Radiol. 2007 Apr;42(4):235-41.

PMID:
17351430
6.

Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.

Dassler K, Roohi F, Lohrke J, Ide A, Remmele S, Hütter J, Pietsch H, Pison U, Schütz G.

Invest Radiol. 2012 Jul;47(7):383-91. doi: 10.1097/RLI.0b013e31824c5a57.

PMID:
22659596
8.

Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling.

Lu CW, Hung Y, Hsiao JK, Yao M, Chung TH, Lin YS, Wu SH, Hsu SC, Liu HM, Mou CY, Yang CS, Huang DM, Chen YC.

Nano Lett. 2007 Jan;7(1):149-54.

PMID:
17212455
9.

Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent.

Nitin N, LaConte LE, Zurkiya O, Hu X, Bao G.

J Biol Inorg Chem. 2004 Sep;9(6):706-12. Epub 2004 Jun 30.

PMID:
15232722
10.

Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles.

Pittet MJ, Swirski FK, Reynolds F, Josephson L, Weissleder R.

Nat Protoc. 2006;1(1):73-9.

PMID:
17406214
11.

(⁹⁹m)Tc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging.

Torres Martin de Rosales R, Tavaré R, Glaria A, Varma G, Protti A, Blower PJ.

Bioconjug Chem. 2011 Mar 16;22(3):455-65. doi: 10.1021/bc100483k. Epub 2011 Feb 21.

PMID:
21338098
12.

In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection.

Jing XH, Yang L, Duan XJ, Xie B, Chen W, Li Z, Tan HB.

Joint Bone Spine. 2008 Jul;75(4):432-8. doi: 10.1016/j.jbspin.2007.09.013. Epub 2008 May 2.

PMID:
18448377
13.

Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines.

Martin AL, Bernas LM, Rutt BK, Foster PJ, Gillies ER.

Bioconjug Chem. 2008 Dec;19(12):2375-84. doi: 10.1021/bc800209u.

PMID:
19053308
14.

Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.

Lin JJ, Chen JS, Huang SJ, Ko JH, Wang YM, Chen TL, Wang LF.

Biomaterials. 2009 Oct;30(28):5114-24. doi: 10.1016/j.biomaterials.2009.06.004. Epub 2009 Jun 26.

PMID:
19560199
15.

Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles.

Dodd CH, Hsu HC, Chu WJ, Yang P, Zhang HG, Mountz JD Jr, Zinn K, Forder J, Josephson L, Weissleder R, Mountz JM, Mountz JD.

J Immunol Methods. 2001 Oct 1;256(1-2):89-105.

PMID:
11516758
16.

The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles.

Lee PW, Hsu SH, Wang JJ, Tsai JS, Lin KJ, Wey SP, Chen FR, Lai CH, Yen TC, Sung HW.

Biomaterials. 2010 Feb;31(6):1316-24. doi: 10.1016/j.biomaterials.2009.11.010. Epub 2009 Dec 3.

PMID:
19959224
17.

Nucleic acid delivery to magnetically-labeled cells in a 2D array and at the luminal surface of cell culture tube and their detection by MRI.

Mykhaylyk O, Steingötter A, Perea H, Aigner J, Botnar R, Plank C.

J Biomed Nanotechnol. 2009 Dec;5(6):692-706.

PMID:
20201231
18.

Combined reporter gene PET and iron oxide MRI for monitoring survival and localization of transplanted cells in the rat heart.

Higuchi T, Anton M, Dumler K, Seidl S, Pelisek J, Saraste A, Welling A, Hofmann F, Oostendorp RA, Gansbacher B, Nekolla SG, Bengel FM, Botnar RM, Schwaiger M.

J Nucl Med. 2009 Jul;50(7):1088-94. doi: 10.2967/jnumed.108.060665. Epub 2009 Jun 12.

19.

Biodistribution study of nanometric hybrid gadolinium oxide particles as a multimodal SPECT/MR/optical imaging and theragnostic agent.

Kryza D, Taleb J, Janier M, Marmuse L, Miladi I, Bonazza P, Louis C, Perriat P, Roux S, Tillement O, Billotey C.

Bioconjug Chem. 2011 Jun 15;22(6):1145-52. doi: 10.1021/bc1005976. Epub 2011 May 18.

PMID:
21545181
20.

Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging.

Zhang C, Wängler B, Morgenstern B, Zentgraf H, Eisenhut M, Untenecker H, Krüger R, Huss R, Seliger C, Semmler W, Kiessling F.

Langmuir. 2007 Jan 30;23(3):1427-34.

PMID:
17241069
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk